Compare KVUE & DHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KVUE | DHI |
|---|---|---|
| Founded | 2022 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Homebuilding |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.9B | 39.0B |
| IPO Year | 2023 | 1995 |
| Metric | KVUE | DHI |
|---|---|---|
| Price | $17.65 | $145.62 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 14 |
| Target Price | $19.45 | ★ $166.08 |
| AVG Volume (30 Days) | ★ 19.7M | 1.9M |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | ★ 4.82% | 1.19% |
| EPS Growth | ★ 40.74 | N/A |
| EPS | 0.25 | ★ 4.27 |
| Revenue | $15,124,000,000.00 | ★ $34,250,400,000.00 |
| Revenue This Year | $4.85 | $0.05 |
| Revenue Next Year | $2.63 | $5.85 |
| P/E Ratio | $67.48 | ★ $34.28 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.02 | $119.54 |
| 52 Week High | $22.87 | $183.62 |
| Indicator | KVUE | DHI |
|---|---|---|
| Relative Strength Index (RSI) | 56.07 | 50.06 |
| Support Level | $16.89 | $144.15 |
| Resistance Level | $17.88 | $150.06 |
| Average True Range (ATR) | 0.38 | 3.94 |
| MACD | -0.01 | 0.47 |
| Stochastic Oscillator | 77.05 | 64.93 |
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
D.R. Horton is the largest homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. The firm has majority ownership of Forestar Group, a publicly traded residential lot development company. D.R. Horton's headquarters are in Arlington, Texas.